Literature DB >> 7796154

Caffeine intake (200 mg) in the morning affects human sleep and EEG power spectra at night.

H P Landolt1, E Werth, A A Borbély, D J Dijk.   

Abstract

Adenosine has been implicated in the physiological regulation of sleep propensity. The adenosine-receptor-antagonist, caffeine (100 mg), administered immediately prior to a nocturnal sleep episode, has previously been shown to lower sleep propensity as indexed by a reduced sleep efficiency, a reduced EEG power density in low delta frequencies and enhanced power density in the frequency range of sleep spindles. To further investigate the role of adenosine in sleep regulation we administered 200 mg of caffeine at 07.10 h and analyzed the sleep stages and EEG power spectra during the subsequent night in nine healthy men. Caffeine levels in saliva decreased from a maximum of 17 mumol/l one hour after intake, to 3 mumol/l immediately prior to the sleep episode starting at 23.00 h. Compared to placebo, sleep efficiency and total sleep time were significantly reduced. EEG power density in nonREM sleep was suppressed in the 0.25-0.5 Hz band and enhanced in the frequency range of sleep spindles (11.25-12.0 Hz and 13.25-14.0 Hz). In REM sleep EEG power density was suppressed in the frequency range of 0.75-4.5 and 5.25-6.0 Hz. The data indicate that a saliva level of caffeine as low as 3 mumol/l directly affects sleep propensity or, alternatively, that the presence of caffeine in the central nervous system during the waking episode reduces the progressive increase of sleep propensity associated with wakefulness.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7796154     DOI: 10.1016/0006-8993(95)00040-w

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  38 in total

Review 1.  Circadian system, sleep and endocrinology.

Authors:  Christopher J Morris; Daniel Aeschbach; Frank A J L Scheer
Journal:  Mol Cell Endocrinol       Date:  2011-09-10       Impact factor: 4.102

2.  Neuropharmacology of Sleep and Wakefulness.

Authors:  Christopher J Watson; Helen A Baghdoyan; Ralph Lydic
Journal:  Sleep Med Clin       Date:  2010-12

3.  Defending sleepwalkers with science and an illustrative case.

Authors:  Rosalind D Cartwright; Christian Guilleminault
Journal:  J Clin Sleep Med       Date:  2013-07-15       Impact factor: 4.062

4.  Association of hostility with sleep duration and sleep disturbances in an employee population.

Authors:  Niklas Grano; Jussi Vahtera; Marianna Virtanen; Liisa Keltikangas-Jarvinen; Mika Kivimaki
Journal:  Int J Behav Med       Date:  2008

Review 5.  The role of sleep hygiene in promoting public health: A review of empirical evidence.

Authors:  Leah A Irish; Christopher E Kline; Heather E Gunn; Daniel J Buysse; Martica H Hall
Journal:  Sleep Med Rev       Date:  2014-10-16       Impact factor: 11.609

Review 6.  Has adult sleep duration declined over the last 50+ years?

Authors:  Shawn D Youngstedt; Eric E Goff; Alexandria M Reynolds; Daniel F Kripke; Michael R Irwin; Richard R Bootzin; Nidha Khan; Girardin Jean-Louis
Journal:  Sleep Med Rev       Date:  2015-08-28       Impact factor: 11.609

7.  Drug testing in children with excessive daytime sleepiness during multiple sleep latency testing.

Authors:  Eliot S Katz; Kiran Maski; Amanda J Jenkins
Journal:  J Clin Sleep Med       Date:  2014-08-15       Impact factor: 4.062

Review 8.  Sleep abnormalities during abstinence in alcohol-dependent patients. Aetiology and management.

Authors:  H P Landolt; J C Gillin
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

9.  Naturalistic Effects of Five Days of Bedtime Caffeine Use on Sleep, Next-Day Cognitive Performance, and Mood.

Authors:  Emma K Keenan; Brian Tiplady; Caroline M Priestley; Peter J Rogers
Journal:  J Caffeine Res       Date:  2014-03-01

10.  Caffeine effects on sleep taken 0, 3, or 6 hours before going to bed.

Authors:  Christopher Drake; Timothy Roehrs; John Shambroom; Thomas Roth
Journal:  J Clin Sleep Med       Date:  2013-11-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.